Apotheceutics

Galderma Canada Inc., established in 1989 as part of the global organization Galderma S.A., specializes in marketing prescription products, over-the-counter skincare, and aesthetic solutions in Canada. They cater to various healthcare professionals, including Dermatologists, General Practitioners, Nurses, Pharmacists, Paediatricians, and Plastic Surgeons. Their product portfolio encompasses prescription drugs, medical dermatology, aesthetics, and therapeutic skincare products targeting skin conditions such as acne, rosacea, psoriasis, steroid-responsive dermatoses, skin cancer, and aging skin. Notable products include Aklief, Apprilon, Clobex, Differin, MetroGel, and Restylane, among others. Located in Baie-D’Urfé, QC, the Montreal manufacturing plant has been operational since 2000, focusing on dermatology products that enhance people's quality of life. Galderma emphasizes employee collaboration and professional growth, with continuous investments to expand its infrastructure and meet the increasing demand for its products. Generated from the website content

O'Hara Technologies Inc, based in Richmond Hill, Canada, is a global leader in pharmaceutical coating innovations, specializing in the manufacturing of solid dosage processing equipment. With a commitment to providing cost-effective solutions and proactive customer support, O'Hara Technologies offers a range of products including tablet coating systems, tray drying ovens, and laboratory fluid bed processors. The company's philosophy revolves around becoming a trusted partner to clients worldwide by delivering high-quality equipment and value-added consulting services to enhance the performance of solid dosage processing equipment. O'Hara Technologies boasts a team of industry-leading service specialists and support professionals dedicated to ensuring trouble-free care of equipment throughout its entire product life cycle. Generated from their website

LEO Pharma Inc, the Canadian affiliate of Denmark-based LEO Pharma AS, has a rich legacy that dates back to its founding in 1908. With a focus on advancing the standard of care for individuals with skin conditions, the company has dedicated decades to research and development in the field of medical dermatology. With over a century of experience in drug development and discovery, LEO Pharma is committed to providing innovative treatment options and improving the lives of patients and their families. The company emphasizes collaboration and partnership within its science innovation ecosystem to further enhance therapeutic expertise in dermatology and thrombosis. Generated from the website